Skip to main content
CDC Website

TB

MDR-TB Planning Toolkit

The MDR-TB Planning Toolkit is designed to help assist countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is intended for countries, technical partners, international organizations, and donors.

12-Dose Regimen for Latent TB Infection

This brochure was developed for clinicians to use with patients while discussing the 12-dose regimen. The brochure contains information on latent TB infection, the 12-dose regimen, treatment schedules, and adverse events. There is space on this brochure to write in treatment schedules and clinic/office contact information.

Guidelines to Measure the Prevalence of Active TB Disease Among Health Care Workers

Although guidelines for population-based TB disease prevalence surveys exist, these cannot readily be used for measuring the prevalence of TB disease among health care workers, specific adaptations are needed. This guide is intended to provide that guidance for the specific setting of health care workers. This guide is designed to be used in combination with the WHO TB Prevalence Surveys: A Handbook.

Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)

This Course is intended as an introduction to multidrug-resistant tuberculosis (MDR-TB) management, and is aimed at medical practitioners involved in the detection, management and treatment of MDR-TB patients, under the guiding principles of the World Health Organization's Stop TB Strategy. The Course aims to facilitate self-study by medical practitioners of contemporary, evidence-based standards for diagnosis and clinical management of MDR-TB in a variety of geographical, economic and social settings.

Global Tuberculosis Report 2012

This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.